DPIIT recognised startup Government of India
Startup India
DNC Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹19.88 Lakh
▲ 8% YoY
Net profit · FY 2024
₹1.16 Lakh
Net margin 5.8%
EBITDA · FY 2024
₹1.58 Lakh
EBITDA margin 8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About DNC Pharmaceuticals Private Limited
Data last updated:
DNC Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 March 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2022PTC161117. Its GSTIN is 36AAJCD1792Q1ZX (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Naresh Chowdary Dirishala and Swathi Gadde.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1 – 62/1 Plot No.115 K.Square Kavuri Hills Madhapur, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.88 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Lakh (net margin 5.8%) and EBITDA of ₹1.58 Lakh (EBITDA margin 8%).
The company is associated with 1 brand: DNC Pharmaceuticals.
DNC Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0059021). For more details, the company can be reached via its website dncpharmaceuticals.com.
Company details
CIN U24239TG2022PTC161117
Registration Number 161117
Incorporation Date 31 March 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0059021
Recognitions & Rankings of DNC Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-02-0059021
Contact details
DNC Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is dncpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1 – 62/1 Plot No.115 K.Square Kavuri Hills Madhapur, Hyderabad, Telangana, India – 500033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of DNC Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
DNC Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
DNC Pharmaceuticals operates one associated brand: DNC Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides contract drug manufacturing, clinical research, and pharmaceutical exports services. | dncpharmaceuticals.com |
Business activity
The main business activity of DNC Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of DNC Pharmaceuticals Private Limited, buy the company report.
Financials of DNC Pharmaceuticals Private Limited
FY 2024 filings availableDNC Pharmaceuticals Private Limited reported revenue of ₹19.88 Lakh (up 8% YoY) for FY 2024.
Revenue · FY 2024
₹19.88 Lakh ▲ 8%
Net profit · FY 2024
₹1.16 Lakh margin 5.8%
EBITDA · FY 2024
₹1.58 Lakh margin 8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
EBITDA CAGR growth
1 year
▲ 20%
Revenue rose 8% in the latest year. EBITDA rose 20% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.58 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.16 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8% | ||
| Net Profit Margin | 5.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of DNC Pharmaceuticals Private Limited, buy the company report.
Board of directors of DNC Pharmaceuticals Private Limited
DNC Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Chowdary Dirishala Also directs: DNC Energy India Private Limited, DNC Infrastructure Private Limited, DNC Aviation Private Limited and 5 more | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
| Swathi Gadde Also directs: DNC Energy India Private Limited, DNC Infrastructure Private Limited, DNC Aviation Private Limited and 5 more | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
DNC Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Infusion Pharmaceuticals Private Limited | ₹20.05 Lakh (FY 2025) | -65.0% | Ambala, Haryana, India | |||
| DNC Pharmaceuticals Private Limitedthis company | ₹19.88 Lakh (FY 2024) | ₹1.16 Lakh | 5.8% | 8.0% | Hyderabad, Telangana, India | |
| Niyogen Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | -10.0% | Sultanganj Patna, Bihar, India | |||
| Astrakind Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | 275.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of DNC Pharmaceuticals Private Limited, buy the company report.
Auditor
DNC Pharmaceuticals Private Limited is audited by K S Subrahmanyam & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S Subrahmanyam & Co | FY 2023 | 017461S |
Shareholding
The shareholding of DNC Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of DNC Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving DNC Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for DNC Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
DNC Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
DNC Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCD1792Q1ZX | Telangana | Active | 20 Apr 2022 |
To see the full GST registrations and return filing status of DNC Pharmaceuticals Private Limited, buy the company report.
Recent activity
DNC Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Naresh Chowdary Dirishala was appointed as Director on 31 Mar 2022.
AGM
Dnc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Dnc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Naresh Chowdary Dirishala was appointed as Director.
Appointed
Swathi Gadde was appointed as Director.
Incorporation
31 Mar 2022
Dnc Pharmaceuticals Private Limited was registered on 31 Mar 2022 with Roc Hyderabad & aged 4 years 7 months as per MCA records.
Frequently asked questions
DNC Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 March 2022 (4+ years old) and is registered under CIN U24239TG2022PTC161117.
DNC Pharmaceuticals has 2 current directors:
- Naresh Chowdary Dirishala - Director
- Swathi Gadde - Director
The latest financial statements of DNC Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of DNC Pharmaceuticals is 36AAJCD1792Q1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of DNC Pharmaceuticals is U24239TG2022PTC161117. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DNC Pharmaceuticals was incorporated on 31 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of DNC Pharmaceuticals by revenue are Infusion Pharmaceuticals Private Limited, Niyogen Pharmaceuticals Private Limited, Astrakind Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Naresh Chowdary Dirishala was appointed as Director on 31 Mar 2022. Swathi Gadde was appointed as Director on 31 Mar 2022.
Yes, DNC Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, DNC Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0059021).
DNC Pharmaceuticals can be reached through the website dncpharmaceuticals.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages